# Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI

> **NCT04812431** · PHASE1,PHASE2 · RECRUITING · sponsor: **S.Biomedics Co., Ltd.** · enrollment: 5 (estimated)

## Conditions studied

- Spinal Cord Injury, Acute
- Spinal Cord Injury at C4 Level With Complete Lesion
- Spinal Cord Injury at C5-C7 Level With Complete Lesion

## Interventions

- **BIOLOGICAL:** Neural precursor cells derived from human embryonic stem cell line

## Key facts

- **NCT ID:** NCT04812431
- **Lead sponsor:** S.Biomedics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-23
- **Primary completion:** 2028-10
- **Final completion:** 2030-09
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2025-05-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04812431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04812431, "Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04812431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*